[ad_1]
Dr. Asparuh Iliev STAFF: BNT
So far, what we know from various experimental data is that the coronavirus has access to the brain, but there is no evidence that it remains there permanently. This was stated in “The day begins with Georgi Lyubenov” at BNT by Dr. Asparuh Iliev from the Brain Infection Laboratory of the University of Bern and an expert in vaccine safety.
“The loss of the sense of smell itself is part of an alteration in the functions of a structure related to the brain. Animal experiments with rats show that the virus has the ability and quality to hide in the brain, but by the At the moment we have no data that the virus remains there What we currently have data and what research shows is that secondary late immune response after illness is the cause of residual complaints after illness, which some describe as post-covid syndrome , and when more prolonged, covid, associated with concentration disorder, with memory impairment, with the ability to perform more complex activities. The same disorders when in the acute phase of the infection are usually caused in the first 5- 6 days directly from the virus, ”explained Dr. Iliev.
At the moment, all companies developing coronavirus drugs are showing promising results, Dr. Iliev said. But they cannot be an alternative to vaccination. Currently, vaccination remains the safest and fastest way to tackle the problem. Tablet therapies will be very interesting and useful for all of us in the future, but they will not be on the market for the next 4-5 months.
“As for vaccination in Switzerland, as well as in Bulgaria and throughout Europe, there is still a shortage of vaccines. The reasons are complex. Vaccination is carried out through so-called vaccination centers, which are quite large centers, and the patients are pre-enrolled in a group schedule. It is expected that the jeeps will soon be included in this vaccination, “he said.
According to him, in Bulgaria the approach is quite flexible due to the “green corridors”, and the main problem is the reluctance to get vaccinated. For him, it is inadmissible to vaccinate corporate clients such as banks, insurance companies and others.
When asked about the reliability of the Astra Zeneca vaccine, Dr. Iliev was categorical:
“My opinion remains that Astra Zeneca is an extremely safe, extremely safe and very good vaccine.”
[ad_2]
